annual ROE:
-18.77%+3.49%(+15.68%)Summary
- As of today (June 22, 2025), ONC annual return on equity is -18.77%, with the most recent change of +3.49% (+15.68%) on December 31, 2024.
- During the last 3 years, ONC annual ROE has risen by +10.38% (+35.61%).
- ONC annual ROE is now -197.00% below its all-time high of 19.35%, reached on December 1, 2013.
Performance
ONC ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly ROE:
-11.54%+7.39%(+39.04%)Summary
- As of today (June 22, 2025), ONC quarterly return on equity is -11.54%, with the most recent change of +7.39% (+39.04%) on March 1, 2025.
- Over the past year, ONC quarterly ROE has increased by +9.53% (+45.23%).
- ONC quarterly ROE is now -38.54% below its all-time high of -8.33%, reached on September 1, 2017.
Performance
ONC quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ONC ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +15.7% | +45.2% |
| 3 y3 years | +35.6% | +72.7% |
| 5 y5 years | +73.0% | +83.3% |
ONC ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +50.8% | at high | +72.8% |
| 5 y | 5-year | at high | +73.0% | at high | +84.7% |
| alltime | all time | -197.0% | +83.5% | -38.5% | +87.5% |
ONC ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | -11.54%(-39.0%) |
| Dec 2024 | -18.77%(-15.7%) | -18.93%(-23.2%) |
| Sep 2024 | - | -24.64%(+67.7%) |
| Jun 2024 | - | -14.69%(-30.3%) |
| Mar 2024 | - | -21.07%(-6.1%) |
| Dec 2023 | -22.26%(-41.6%) | -22.45%(-2.9%) |
| Sep 2023 | - | -23.11%(-40.5%) |
| Jun 2023 | - | -38.85%(-1.2%) |
| Mar 2023 | - | -39.31%(+3.4%) |
| Dec 2022 | -38.11%(+30.7%) | - |
| Dec 2022 | - | -38.01%(-10.4%) |
| Sep 2022 | - | -42.42%(+1.5%) |
| Jun 2022 | - | -41.79%(-1.2%) |
| Mar 2022 | - | -42.29%(+22.9%) |
| Dec 2021 | -29.15%(-56.5%) | -34.40%(-2.7%) |
| Sep 2021 | - | -35.35%(-3.3%) |
| Jun 2021 | - | -36.56%(+7.4%) |
| Mar 2021 | - | -34.05%(-39.2%) |
| Dec 2020 | -67.04%(-3.5%) | -55.97%(-11.6%) |
| Sep 2020 | - | -63.31%(-16.3%) |
| Jun 2020 | - | -75.64%(+9.6%) |
| Mar 2020 | - | -69.01%(+5.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | -69.45%(+25.6%) | -65.69%(+30.4%) |
| Sep 2019 | - | -50.38%(+23.5%) |
| Jun 2019 | - | -40.79%(-12.0%) |
| Mar 2019 | - | -46.37%(-3.6%) |
| Dec 2018 | -55.28%(+208.0%) | -48.08%(+14.6%) |
| Sep 2018 | - | -41.95%(+48.3%) |
| Jun 2018 | - | -28.28%(+30.2%) |
| Mar 2018 | - | -21.72%(+11.0%) |
| Dec 2017 | -17.95%(-67.8%) | -19.56%(+134.8%) |
| Sep 2017 | - | -8.33%(-87.9%) |
| Jun 2017 | - | -68.79%(+22.1%) |
| Mar 2017 | - | -56.33%(+1.9%) |
| Dec 2016 | -55.81%(-51.1%) | -55.29%(-16.2%) |
| Sep 2016 | - | -65.95%(+12.8%) |
| Jun 2016 | - | -58.45%(-6.1%) |
| Mar 2016 | - | -62.27%(-15.5%) |
| Dec 2015 | -114.10%(+60.9%) | -73.66%(+72.3%) |
| Sep 2015 | - | -42.76%(-1.2%) |
| Jun 2015 | - | -43.28%(-53.0%) |
| Mar 2015 | - | -92.06%(+75.6%) |
| Dec 2014 | -70.93%(-466.6%) | -52.43% |
| Dec 2013 | 19.35% | - |
FAQ
- What is BeOne Medicines annual return on equity?
- What is the all time high annual ROE for BeOne Medicines?
- What is BeOne Medicines annual ROE year-on-year change?
- What is BeOne Medicines quarterly return on equity?
- What is the all time high quarterly ROE for BeOne Medicines?
- What is BeOne Medicines quarterly ROE year-on-year change?
What is BeOne Medicines annual return on equity?
The current annual ROE of ONC is -18.77%
What is the all time high annual ROE for BeOne Medicines?
BeOne Medicines all-time high annual return on equity is 19.35%
What is BeOne Medicines annual ROE year-on-year change?
Over the past year, ONC annual return on equity has changed by +3.49% (+15.68%)
What is BeOne Medicines quarterly return on equity?
The current quarterly ROE of ONC is -11.54%
What is the all time high quarterly ROE for BeOne Medicines?
BeOne Medicines all-time high quarterly return on equity is -8.33%
What is BeOne Medicines quarterly ROE year-on-year change?
Over the past year, ONC quarterly return on equity has changed by +9.53% (+45.23%)